Karyopharm Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). 

CEO
Richard A. Paulson
CEORichard A. Paulson
Employees
325
Employees325
Headquarters
Newton, Massachusetts
HeadquartersNewton, Massachusetts
Founded
2008
Founded2008
Employees
325
Employees325

KPTI Key Statistics

Market cap
152.58M
Market cap152.58M
Price-Earnings ratio
-1.10
Price-Earnings ratio-1.10
Dividend yield
—
Dividend yield—
Average volume
1.20M
Average volume1.20M
High today
$1.43
High today$1.43
Low today
$1.22
Low today$1.22
Open price
$1.42
Open price$1.42
Volume
737.60K
Volume737.60K
52 Week high
$4.71
52 Week high$4.71
52 Week low
$0.6174
52 Week low$0.6174

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.